Drug interactions between Depakote Sprinkles and Lamictal
| Results for the following 2 drugs: |
|---|
| Depakote Sprinkles (divalproex sodium) |
| Lamictal (lamotrigine) |
Interactions between your selected drugs
lamotrigine ↔ divalproex sodium
Applies to:Lamictal (lamotrigine) and Depakote Sprinkles (divalproex sodium)
ADJUST DOSE: Coadministration with valproic acid has been shown to significantly increase the plasma concentrations of lamotrigine and the risk of potentially serious and life-threatening rash induced by lamotrigine, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Severe, disabling tremors and ataxia have also been reported. The mechanism is competitive inhibition of lamotrigine glucuronidation by valproic acid. Pharmacokinetic data indicate that valproic acid can more than double the elimination half-life of lamotrigine, whether given with or without enzyme-inducing antiepileptic drugs (EIAEDs) such as carbamazepine, phenytoin, and phenobarbital. In a study of eight patients treated with lamotrigine, half of whom also received EIAEDs, valproic acid 200 mg/day and 1000 mg/day (each for 3 weeks) increased the dose-corrected area under the plasma concentration-time curve (AUC) of lamotrigine by an average of 84% and 160%, respectively. Corresponding lamotrigine half-life increased by an average of 37% and 150%. Additive or synergistic pharmacodynamic effects may also contribute to the interaction, which some investigators suggest is responsible in some patients for enhanced antiepileptic efficacy beyond that attained from mere increases in plasma lamotrigine levels. Lamotrigine appears to have negligible to minor effects on the pharmacokinetics of valproic acid.
MANAGEMENT: When coadministered with valproic acid, the dosage of lamotrigine should be half that required in the absence of valproic acid. Patients should be advised to promptly notify their physician if they experience early manifestations of hypersensitivity such as fever, angioedema, and lymphadenopathy, even if a rash is not evident. Lamotrigine should be discontinued if an alternative etiology for these symptoms cannot be established. Likewise, the drug should be discontinued at the first sign of rash, unless the rash is clearly not drug-related.
See also...
Drug Interaction Classification
The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
